Latanoprost Ratiopharm (Latanoprost)

Latanoprost binds to prostaglandin F (FP) receptors in the eye, stimulating remodeling of the extracellular matrix in the ciliary body. This enhances uveoscleral outflow of aqueous humor, thereby reducing intra‑ocular pressure.

The dosing regimen for Latanoprost Ratiopharm is determined by the prescribing healthcare professional. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact dose and schedule should follow the prescriber’s instructions.

The safety of Latanoprost in pregnancy or while breastfeeding has not been definitively established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and the decision should be made in consultation with a healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analog class, which generally offers once‑daily dosing and strong intra‑ocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogs often have a more favorable dosing convenience and efficacy profile, though individual response may vary.

Latanoprost eye drops should be stored at room temperature, below 25 °C, in the original packaging. Protect the product from light and moisture, and keep the bottle tightly closed when not in use.

The medication is applied as a sterile eye drop. The patient should wash their hands, tilt the head back, pull down the lower eyelid to create a pocket, and place one drop into the conjunctival sac. Close the eye gently and avoid blinking excessively.

Serious risks, though rare, include severe allergic reactions, uveitis or iritis, and macular edema, which can affect central vision. Patients should seek immediate medical attention if they experience sudden eye pain, vision changes, swelling, or systemic allergic symptoms.

Latanoprost should be avoided in patients with known hypersensitivity to latanoprost or any component of the formulation, active ocular infections, or those who have had a severe reaction to other prostaglandin analogs. Caution is also advised for individuals with a history of uveitis.